Hidekatsu Fukuta
Papers
1
Total Citations
33
H-Index
1
About
Hidekatsu Fukuta is a leading urological surgeon whose work centers on advancing minimally invasive techniques for kidney stone treatment, particularly percutaneous nephrolithotomy (PCNL). His most notable contribution is a landmark 2022 randomized, single-blind clinical trial comparing robotic-assisted fluoroscopic-guided renal access with traditional ultrasound-guided access for mini-PCNL. This study, which has already garnered 33 citations, directly addresses a critical challenge in endourology: optimizing access precision while minimizing radiation exposure and complications. By demonstrating the safety and efficacy of robotic guidance, Fukuta has helped pave the way for more standardized, reproducible renal access—a key step toward improving patient outcomes in complex stone disease. His research sits at the intersection of robotics, imaging, and surgical technique, reflecting a broader commitment to integrating cutting-edge technology into everyday urological practice. With a growing citation impact and a focus on high-quality clinical evidence, Fukuta is establishing himself as a key voice in the evolution of stone surgery, offering practical solutions that benefit both surgeons and patients.
Research Focus
Key Achievements
Top Papers
- 1